Johnson & Johnson Investing Activities - Other 2010-2025 | JNJ
Johnson & Johnson annual/quarterly investing activities - other history and growth rate from 2010 to 2025. Investing activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the investing activities section of the Cash Flows Statement
- Johnson & Johnson investing activities - other for the quarter ending March 31, 2025 was $252M, a 84.2% decline year-over-year.
- Johnson & Johnson investing activities - other for the twelve months ending March 31, 2025 was $503M, a 113.92% decline year-over-year.
- Johnson & Johnson annual investing activities - other for 2024 was $-0.44B, a 87.14% decline from 2023.
- Johnson & Johnson annual investing activities - other for 2023 was $-3.421B, a 615.69% increase from 2022.
- Johnson & Johnson annual investing activities - other for 2022 was $-0.478B, a 62.59% increase from 2021.
Johnson & Johnson Annual Investing Activities - Other
(Millions of US $) |
| 2024 |
$-440 |
| 2023 |
$-3,421 |
| 2022 |
$-478 |
| 2021 |
$-294 |
| 2020 |
$-1,508 |
| 2019 |
$382 |
| 2018 |
$-464 |
| 2017 |
$-234 |
| 2016 |
$-123 |
| 2015 |
$-103 |
| 2014 |
$-299 |
| 2013 |
$-266 |
| 2012 |
$38 |
| 2011 |
$-778 |
| 2010 |
$-38 |
| 2009 |
$-109 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$364.111B |
$88.821B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
